On February 23, 2022, Mednax, Inc. announced that Roger Mack Hinson, M.D., President of the Company's Pediatrix and Obstetrix Medical Group, would transition from such position, effective as of June 1, 2022 (the Effective Date). Dr. Hinson's transition from his role as President of the Company's Pediatrix and Obstetrix Medical Group is a termination without Cause pursuant to that certain Amended and Restated Employment Agreement, effective September 27, 2020, by and between Dr. Hinson and a wholly-owned subsidiary of the Company. The Company and Dr. Hinson intend to enter into a consulting agreement pursuant to which Dr. Hinson will continue to serve as an advisor to the Company following the Effective Date.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.4 USD | +2.64% |
|
+8.66% | -20.43% |
Jul. 01 | Pediatrix Medical Group, Inc.(NYSE:MD) dropped from Russell 2000 Value-Defensive Index | CI |
Jul. 01 | Pediatrix Medical Group, Inc.(NYSE:MD) dropped from Russell 2000 Defensive Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.43% | 613M | |
+19.84% | 84.94B | |
-25.24% | 74.07B | |
-1.34% | 26.15B | |
+4.56% | 18.03B | |
-9.29% | 17.38B | |
+4.52% | 16.01B | |
+78.16% | 13.7B | |
+77.84% | 13.13B | |
-26.14% | 12.74B |
- Stock Market
- Equities
- MD Stock
- News Pediatrix Medical Group, Inc.
- MEDNAX, Inc. Announces Resignation of Roger Mack Hinson as President of Pediatrix and Obstetrix Medical Group, Effective as of June 1, 2022